Test your knowledge in our Biology Week cancer quiz.
Day 3: A Focus on Cancer
Celebrating Biology Week 2015
Cancer is a comprehensive disease with no boundaries or barriers. It affects a lot of people irrespective of gender, age or ethnicity or socio-economic backgrounds.
Cancer has evolved from more than just a rapidly dividing cell to a leading cause of death resulting in more than 8 million deaths worldwide.
Here, we present interesting discussions from accomplished cancer researchers who share their insight on fighting cancer using scientific collaborations and technological advancements.
Quiz: How well do you know cancer?
Get to know our Editors!
Editor-in-Chief of Cancer Cell International reveals his thoughts on cancer research including how technology has advanced and what he thinks it will take to eradicate cancer in the future.
Daniel Chan, the Editor-in-Chief of Clinical Proteomics provides a global perspective on cancer by providing some insights on cancer research in China and the United States.
Jan Kitajewski, the Editor-in-Chief of Vascular Cell highlights his important research breakthroughs in Notch signaling, shares his perspectives on scientific collaborations.
Read our Top Cancer Articles
- Relevance of tumor-infiltrating lymphocytes in breast cancer
- Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
- New horizons in tumor microenvironment biology: challenges and opportunities
- Characterization of interaction of magnetic nanoparticles with breast cancer cells
- The effects of multifunctional MiR-122-loaded graphene-gold composites on drug-resistant liver cancer
- Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells
- Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis
- Silicon particles as trojan horses for potential cancer therapy
- CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer
- Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells
- Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
- Widespread intron retention diversifies most cancer transcriptomes
- Mutation signatures implicate aristolochic acid in bladder cancer development
- Development of cancer genetic services in the UK: A national consultation
- Altering cancer transcriptomes using epigenomic inhibitors
- Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis
- Autophagy capacity and sub-mitochondrial heterogeneity shape Bnip3-induced mitophagy regulation of apoptosis
- Cancer stem cells – the current status of an old concept: literature review and clinical approaches
- A colorectal cancer prediction model using traditional and genetic risk scores in Koreans
- Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
- Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer
- Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
- Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium
- Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation
More from SpringerOpen:
- Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer
- New prospects for PET in prostate cancer imaging: a physicist's viewpoint
- Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model
- Managing the advanced cancer patient in the Australian emergency department environment: findings from a national survey of emergency department clinicians
- Pectoral nerve block combined with general anesthesia for breast cancer surgery: a retrospective comparison
- Cancer therapy: know your enemy?
- Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
- Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways
For more Cancer articles visit our website and access over 80,000 open access articles!